Clinical Trial: ECOG-ACRIN EAQ162CD

ECOG-ACRIN EAQ162CD

Status: Closed

NCT#03516942

Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent

EAQ162CD closed to accrual Monday, July 6, 2020.

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved